Seguir
Sisir Nandi
Sisir Nandi
Professor and Head, GIPER (affiliated to Uttarakhand Technical
No hay ninguna dirección de correo electrónico verificada. - Página principal
Título
Citado por
Citado por
Año
Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks
S Nandi, M Vracko, MC Bagchi
Chemical biology & drug design 70 (5), 424-436, 2007
812007
Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers
KRP H Roy, C K Brahma, Sisir Nandi,
International Journal of Applied and Basic Medical Research 3, 55-63, 2013
682013
3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
S Nandi, MC Bagchi
Molecular diversity 14, 27-38, 2010
682010
Potential inhibitors of protein tyrosine phosphatase (PTP1B) enzyme: promising target for type-II diabetes mellitus
S Nandi, M Saxena
Current Topics in Medicinal Chemistry 20 (29), 2692-2707, 2020
372020
The antiviral and antimalarial drug repurposing in quest of chemotherapeutics to combat COVID-19 utilizing structure-based molecular docking
S Nandi, M Kumar, M Saxena, AK Saxena
Combinatorial Chemistry & High Throughput Screening 24 (7), 1055-1068, 2021
262021
Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors
S Nandi, A Monesi, V Drgan, F Merzel, M Novič
Chemistry Central Journal 7, 1-13, 2013
262013
Atranorin, an antimicrobial metabolite from lichen Parmotrema rampoddense exhibited in vitro anti-breast cancer activity through interaction with Akt activity
A Harikrishnan, V Veena, B Lakshmi, R Shanmugavalli, S Theres, ...
Journal of Biomolecular Structure and Dynamics 39 (4), 1248-1258, 2021
252021
Combinatorial design and virtual screening of potent anti-tubercular fluoroquinolone and isothiazoloquinolone compounds utilizing QSAR and pharmacophore modelling
S Nandi, S Ahmed, AK Saxena
SAR and QSAR in Environmental Research 29 (2), 151-170, 2018
232018
Exploring the potential inhibition of candidate drug molecules for clinical investigation based on their docking or crystallographic analyses against M. tuberculosis enzyme targets
R Dey, S Nandi, A Samadder, A Saxena, AK Saxena
Current Topics in Medicinal Chemistry 20 (29), 2662-2680, 2020
212020
Recent advances in ligand and structure based screening of potent quorum sensing inhibitors against antibiotic resistance induced bacterial virulence
S Nandi
Recent Patents on Biotechnology 10 (2), 195-216, 2016
202016
Activity Prediction of Some Nontested Anticancer Compounds Using GA‐Based PLS Regression Models
S Nandi, MC Bagchi
Chemical biology & drug design 78 (4), 587-595, 2011
192011
QSAR of aminopyrido [2, 3-d] pyrimidin-7-yl derivatives: anticancer drug design by computed descriptors
S Nandi, MC Bagchi
Journal of Enzyme Inhibition and Medicinal Chemistry 24 (4), 937-948, 2009
192009
Pelargonidin mediated selective activation of p53 and parp proteins in preventing food additive induced genotoxicity: an in vivo coupled in silico molecular docking study
R Dey, S Nandi, A Samadder
European Journal of Pharmaceutical Sciences 156, 105586, 2021
182021
In silico design of potent EGFR kinase inhibitors using combinatorial libraries
S Nandi, MC Bagchi
Molecular Simulation 37 (03), 196-209, 2011
172011
An updated patent review on drugs for the treatment of tuberculosis (2018-present)
S Ahmed, S Nandi, AK Saxena
Expert Opinion on Therapeutic Patents 32 (3), 243-260, 2022
162022
Natural Sourced inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated signaling pathways as potential anticancer agents
S Nandi, R Dey, A Samadder, A Saxena, AK Saxena
Current Medicinal Chemistry 29 (2), 212-234, 2022
162022
In-silico modeling in drug metabolism and interaction: Current strategies of lead discovery
H Roy, S Nandi
Current Pharmaceutical Design 25 (31), 3292-3305, 2019
162019
Exploring spike protein as potential target of novel coronavirus and to inhibit the viability utilizing natural agents
S Nandi, H Roy, A Gummadi, AK Saxena
Current Drug Targets 22 (17), 2006-2020, 2021
142021
Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique
H Roy, CK Brahma, R Kumar, S Nandi
Drug Invention Today 5 (3), 259-266, 2013
142013
Stem Cell therapy in combination with naturopathy: Current progressive management of diabetes and associated complications
A Saha, A Samadder, S Nandi
Current Topics in Medicinal Chemistry 23 (8), 649-689, 2023
132023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20